Let’s not forget about the end of 2019…….The company new way back when how they achieved the significant markers, that’s the 2018 clinical human phase 2 trials, I would imagine they would have a pretty good idea how these results are going to play out and if true old mate only several days ago talking to one of the Directors ref 200 people in the Sydney trials…….that in itself is Solid. I’m prepared to give MM a little more credit.
BIT Price at posting:
3.0¢ Sentiment: Buy Disclosure: Held
